Wolverine Stack: BPC-157 and TB-500, Explained

What Is the Wolverine Stack?

The wolverine stack is two peptides taken together: BPC-157 Explore PeRxBPC-157The Body Protection CompoundView peptide and TB-500. That is the whole recipe. No secret third ingredient, no proprietary ratio, no trademark. It is a nickname that bodybuilding forums and biohacking podcasts attached to the pairing somewhere in the mid-2010s, and it stuck because the reference explains the pitch in one word. Wolverine is the comic-book character whose defining ability is healing from any injury, and the stack is marketed, informally and enthusiastically, as the closest thing peptides offer to that.

It is worth being clear about what kind of thing the name is, because the search results blur it. The wolverine stack is not a drug. It is not a product with a standard formula. It is a meme-era shorthand that different vendors fill with different contents at different concentrations. When a podcast guest, a forum thread, and a research-chemical site all say "wolverine stack," they are describing the same idea and potentially three different vials. The idea itself, though, is consistent: pair the most-studied repair peptide with a systemic recovery peptide and cover more of the healing process than either would alone.

The name has cousins. Add GHK-Cu Explore PeRxGHK-CuThe Skin Rejuvenation PeptideView peptide to the pair and forums call it GLOW; add KPV on top of that and it becomes KLOW. If you are trying to decide between the two-, three-, and four-peptide versions, our GLOW vs KLOW vs wolverine stack comparison Read nextGLOW vs KLOW vs Wolverine Stack: Which One?Three nicknames, four peptides, one recurring confusion. GLOW is GHK-Cu plus BPC-157 plus TB-500. KLOW is GLOW with KPV added. The Wolverine stack is BPC-157 and TB-500 on their own. Here is what each name actually contains, which goal each one fits, what a prescribing clinic dispenses in their place, and why an $80 research vial and a $349 pharmacy vial are not the same product.Read article breaks them down head to head. This page stays on the original pair: what it is, what it does, and what you can honestly expect from it.

What's Actually in It

Two peptides, two different jobs. The reason this particular pair became the recovery combination, rather than any of the dozens of other possible pairings, is that the mechanisms barely overlap.

BPC-157: the local worker

BPC-157 is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. In animal studies it promotes angiogenesis, the growth of new blood vessels, through the VEGF pathway, and it recruits growth-factor signaling at the site of damage. That matters most for tendons and ligaments, which heal slowly precisely because their blood supply is poor. It is the more studied half of the stack by a wide margin, with a literature spanning three decades, and our complete BPC-157 guide Read nextBPC-157 Peptide: Benefits, Dosage & Complete GuideA peptide discovered in a Croatian lab in the early '90s is now one of the most studied healing compounds in regenerative medicine. Here's what the science actually says, where it came from, and what you should know before starting.Read article covers it in depth.

Hsieh MJ et al., "Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation," Journal of Molecular Medicine, 2017. Cell and rodent models. View study

TB-500: the systemic half

TB-500 is a synthetic fragment of thymosin beta-4, a protein your body uses to regulate actin, the structural scaffolding that lets cells physically move. Where BPC-157 concentrates its effects near where you inject it, thymosin beta-4 circulates and works body-wide, helping repair cells migrate to damaged tissue wherever it is. Our TB-500 guide Read nextTB-500 Peptide: What It Is and How It WorksTB-500 is a lab-made fragment of thymosin beta-4, a protein nearly every cell in your body uses to move repair machinery to where damage is. This guide covers what TB-500 actually is, the actin mechanism behind it, what the research does and does not show, side effects, and why it reaches patients only inside prescribed combination vials.Read article tells its full story, including the part most sales pages skip: the wound-healing research behind the mechanism was done on the full thymosin beta-4 protein, not on the fragment sold as TB-500.

Malinda KM et al., "Thymosin beta4 accelerates wound healing," Journal of Investigative Dermatology, 1999. Animal models of the full thymosin beta-4 protein. View study

Why these two together

One works at the injury, one works everywhere. One rebuilds blood supply, one moves repair cells. The combination covers the local bottleneck and the systemic environment at the same time, which is a genuinely reasonable division of labor even before you ask what the evidence shows. The full reasoning, including the injuries where one peptide alone is enough, lives in why we pair BPC-157 and TB-500 Read nextWhy We Pair BPC-157 With TB-500BPC-157 and TB-500 are both repair peptides, but they cover different ground. BPC-157 works fast and focal, strongest at a specific injury and in the gut. TB-500 works broad and systemic, moving repair cells across the whole body. The pairing is not automatic. Here is how a provider decides whether you need both, or whether BPC-157 on its own does the job.Read article .

Some circles keep adding. GHK-Cu for skin and connective tissue, KPV for inflammation, a growth hormone secretagogue like CJC-1295/Ipamorelin Explore PeRxCJC-1295/IpamorelinPulsatile Growth Hormone ReleaseView peptide alongside for body composition. Each addition has its own rationale and its own evidence gaps. The two-peptide core is where the recovery case is strongest, and it is what this article means by the wolverine stack from here on.

What the Research Supports

Here is the sentence that should open every honest article on this topic: no clinical trial has ever tested the wolverine stack. Nobody has run BPC-157 plus TB-500 against a placebo, against either peptide alone, or against standard care in humans. Everything claimed about the combination is inference from single-ingredient research, and the two ingredients are not equally supported.

BPC-157 has the deeper bench: over 100 published papers showing consistent healing effects across tendon, ligament, muscle, and gut models. Nearly all of it is rodent work, and much of it comes from a single research group in Zagreb, two facts that deserve more airtime than they get. The human data is thin but not zero. A 2021 report on intra-articular BPC-157 injections for knee pain found that most patients had significant relief lasting months. It was small, uncontrolled, and unblinded, which means it can suggest but not prove.

Lee E, Padgett B, "Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain," Alternative Therapies in Health and Medicine, 2021. Small human case series, no control group. View study

TB-500 is where the citation game gets slippery. The parent protein, thymosin beta-4, went through preclinical work and early human wound-healing studies, including results summarized by Treadwell and colleagues in 2012 showing accelerated dermal healing in animal models and in patients. Those findings are routinely quoted as evidence for TB-500. They are evidence for thymosin beta-4. The synthetic fragment has no published human dosing data of its own, no pharmacokinetics in people, no safety trial. The mechanism is plausible and the animal work is real, but the human file on the actual molecule in the vial is empty.

Treadwell T et al., "The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients," Annals of the New York Academy of Sciences, 2012. View study

So what does the research support, stated plainly? A strong mechanistic case and consistent animal results for BPC-157, a plausible mechanism borrowed from a related molecule for TB-500, and a combination rationale that makes biological sense but has never been formally tested. That is more than nothing and less than proof. Anyone telling you otherwise, in either direction, is selling something.

Wolverine Stack Side Effects

The honest framing first: because no controlled safety trial has studied either peptide at recovery doses, side-effect knowledge comes from patient reports and from what is known about the mechanisms. Within those limits, the commonly reported effects are mild.

Injection site reactions top the list: brief redness, a small welt, or soreness where the needle went in, usually gone within a day. Rotating injection spots handles most of it. Brief lightheadedness after a dose shows up often enough in reports that injecting while seated for the first week is a sensible habit. Occasional reports of headache, fatigue, or mild nausea cluster around the first doses and tend to fade as the body adjusts.

The exclusions matter more than the common effects. Both peptides act on growth-factor and cell-migration pathways, which is exactly what you want for a healing tendon and exactly what you do not want near a tumor. Anyone with active cancer or a recent cancer history should not use the wolverine stack without oncologist clearance; this is a precaution based on mechanism rather than observed harm, and it is the responsible position. Pregnancy and breastfeeding are excluded outright because no safety data exists. The deeper unknown is long-term use: nobody has studied years of continuous exposure, which is one reason the prescribed protocol cycles off rather than running indefinitely.

Seek immediate care for signs of a serious reaction: swelling of the face or throat, difficulty breathing, or a rapid heartbeat after a dose. For the broader picture of what patients report across peptide therapies and when to call a provider, see our peptide side effects guide Read nextPeptide Side Effects: Normal vs. Red Flag (2026)Most peptide side effects are mild local reactions that resolve in a day. A smaller set of systemic effects depends on the pathway the peptide acts on. And a third category, the one worth paying attention to, points to a problem with the product or the patient that should pause the protocol. Here is how to tell them apart.Read article .

The Prescription Version

Most wolverine stack content assumes you will buy two vials of powder from a research-chemical site, mix them yourself, and figure out a protocol from forum threads. That version exists, it is cheap, and it is labeled "not for human use" for a reason: no prescription, no screening, no verification of what is actually in the vial, and a concentration that depends on how much liquid you added at your kitchen counter.

The prescribed version replaces all of that with one vial. Through PeRx, the wolverine stack is dispensed as the BPC/TB-500 combo Explore PeRxBPC/TB-500The Ultimate Recovery ComboView peptide : both peptides compounded together by a licensed US 503A pharmacy at a fixed, matched concentration of 3 mg BPC-157 and 3 mg TB-500 per mL in a 5 mL vial. The 1:1 ratio is identical in every dose because the pharmacy set it, not because you measured carefully. The vial ships fully reconstituted and ready to use, refrigerated, with insulin syringes, alcohol swabs, and an injection guide in the box. Before any of that ships, a licensed provider reviews your health intake, which is where cancer history, pregnancy, and medication conflicts get caught.

Your PeRx provider prescribes the protocol, and the label on your vial is the final word. The arithmetic behind those numbers, units to milligrams, weekly totals, vial math, lives in the wolverine stack dosage chart, and the same math for the blend under its pharmacy name is in the BPC-157/TB-500 dosage chart Read nextBPC-157/TB-500 Dosage Chart: Units, mg, CycleThe prescribed BPC-157/TB-500 blend has one concentration and one dose, and every number on this page follows from those two facts. Draw 20 units and you get 0.6 mg of each peptide. Here is the full arithmetic: the dosage chart, units on an insulin syringe, per-day and per-week totals, how the capsules dose differently, and what a month actually costs.Read article . For how the prescription category differs from research-use products in general, see research peptides vs prescription peptides Read nextResearch Peptides vs Prescription Peptides (2026)An honest comparison for the patient who already uses peptides, what the 'Not for Human Use' label actually means, the real quality differences, and the practical steps to switch from research-chemical sourcing to a prescription supply.Read article .

BPC/TB-500 Combo

The prescribed wolverine stack in a single vial: 3 mg/mL of each peptide, matched 1:1 in every dose, compounded by a US 503A pharmacy and third-party tested for purity and sterility. It ships fully reconstituted and ready to use, so there is no mixing, no math, and no guessing what is in the solution.

Prescribed by a licensed provider after a health screening. From $299 per month, syringes and supplies included.

One vial, both peptides, pharmacy-set concentrations.

Shop Now

BPC/TB-500 Capsules

The wolverine stack in a capsule. Both peptides in a daily oral dose, no needles, no refrigeration, easy to travel with. Oral delivery suits the gut side of the BPC-157 story especially well, since the peptide was derived from a gastric protein in the first place.

Oral and injected milligrams are not interchangeable, particularly for TB-500, so the capsules are best thought of as a needle-free entry point or a travel companion to the injectable rather than a milligram-for-milligram swap. From $225 for 30 capsules.

The same pair, needle-free.

Shop Now

Wolverine Stack Before and After: Honest Expectations

Search "wolverine stack before and after" and you will find dramatic recovery stories with no baseline, no imaging, and no way to know what healing would have happened anyway. Set those aside. Nobody has measured the combination in a trial, so nobody can honestly quote a response rate or a timeline with confidence. What follows is the arc most patients describe on the prescribed six-week protocol, offered as orientation rather than prediction.

And the outcome nobody posts about: some people finish a cycle and feel nothing. With no controlled data, no one can say how often that happens. If a full six-week course changes nothing, the answer is not a bigger dose. It is a conversation about whether the injury needs something else entirely, which can include imaging, physical therapy, or a surgeon.

What Reddit Gets Right and Wrong

A large share of wolverine stack searches include the word "reddit," because people sensibly want reports from humans rather than sales pages. Forum threads are genuinely useful for some things and reliably misleading for others, and it is worth knowing which is which.

What the forums get right. The texture of daily use is accurately reported: what injection-site reactions feel like, the lightheadedness some people get, the fact that results build over weeks rather than days. The skepticism about sourcing is also earned. Threads are full of people wondering whether their gray-market vial contained what the label claimed, and independent testing of research-chemical peptides has repeatedly found underdosed and contaminated products, so that anxiety is rational. And the honest threads exist: for every glowing report there is a "ran it for eight weeks, felt nothing" post, which matches what the absence of trial data would predict.

What the forums get wrong. Three things, mostly. First, dosing charts travel without their context: a protocol written for someone's home-mixed 10 mg vial gets applied to a completely different concentration, which is how people end up taking several times the intended amount. Second, survivorship bias runs the discourse. People who recover post enthusiastically, people who felt nothing drift away, and injuries heal on their own timelines anyway, so the visible record skews positive in a way no one can correct for. Third, the evidence gets upgraded in transit: the thymosin beta-4 human wound data becomes "TB-500 is human-tested," rodent tendon studies become "proven for tendons," and by the tenth repost the wolverine stack has a clinical file it does not actually have.

The reasonable takeaway is to read forums for logistics and lived texture, and read the primary literature, or an honest summary of it, for claims about what the peptides do. The two sources answer different questions.

Wolverine Stack: Common Questions